Clinical Trial Update: Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing twice-daily insulin lispro low mixture with a once-daily long-acting insulin in type 2 diabetes patients previously treated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin lispro low mixture (insulin lispro low mixture)
• Long-acting insulin comparator (long-acting insulin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED